METHOD OF PREVENTING BRONCHOPULMONARY DYSPLASIA IN NEWBORN BABIES WITH VERY LOW AND EXTREMELY LOW BODY WEIGHT AT BIRTH Russian patent published in 2011 - IPC A61H31/02 A61K38/17 A61K9/12 A61P11/00 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to children's anesthesiology and resuscitation science, and can be used as prevention of bronchopulmonary dysplasia in newborn babies with very low and extremely low body weight. For this purpose, to newborn babies, who have been for not less than 7 days of life on non-invasive ALV in mode Biphasic/DuoPAP through nasal cannulas or in mode CPAP through nasal cannulas and on invasive ALV, introduced is "Surfactant BL" in single dose 53-75 mg/kg. Introduction is performed from 8 to 27 days of life inclusive, in sessions 10-15 minutes long depending on volume of Surfactant BL suspension by nebuliser with aerosol generator OnQ Aeroneb® Pro. At most 5 sessions are carried out.

EFFECT: method makes it possible to prevent development of bronchopulmonary dysplasia in said category of patients due to introduction of surfactant BL, which contains surfactant-associated proteins by means of nebuliser, making it possible to introduce medication at rate, optimal for alveolar deposition, preserving its molecular integrity.

4 tbl, 4 ex